Newsfeeds - Spark Newswire

1 minute read

Uncategorized

enVVeno Medical Corporation Completes Rebrand

Today, 2:20 AM

enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, announced today that it has successfully completed

HJLI

1 minute read

Hancock Jaffe To Rebrand As enVVeno Medical

By Vandana Singh

Today, 2:20 AM

Hancock Jaffe Laboratories Inc (NASDAQ:HJLI) will change its name to enVVeno Medical Corporation and start under a new ticker, “NVNO,” from October…

HJLI

3 minute read

News

Hancock Jaffe Announces Co. Will Changing Name To enVVeno Medical Corporation And Ticker Symbol To NASDAQ: NVNO, Effective October 1, 2021

By Benzinga Newsdesk

Today, 2:20 AM

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a medical device company focused on improving the standard of care in the treatment of venous disease, announced

HJLI

2 minute read

Hancock Jaffe Laboratories Announces $20M Registered Direct Offering Priced At-the-Market Under NASDAQ Rules

By Benzinga Newsdesk

Today, 2:20 AM

Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has entered into a definitive agreement with a fund managed by Perceptive

HJLI

1 minute read

Hancock Jaffe Highlights Two-Year Data For Venous Insufficiency Valve

By Vandana Singh

Today, 2:20 AM

Hancock Jaffe Laboratories Inc (NASDAQ:HJLI) announced two-year data post-VenoValve implantation in eight patients. Data will be presented at the Society for…

HJLI

5 minute read

Hancock Jaffe Highlights Presentation Of Two-Year VenoValve Data At Society For Vascular Surgery Annual Meeting

By Bill Haddad

Today, 2:20 AM

Two-year VenoValve® data shows average improvements in reflux, disease manifestations and pain, of 63%, 60%, and 93%, respectively Patients with venous ulcers who experienced dramatic ulcer healing

HJLI